Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

BACKGROUND: Durvalumab as maintenance treatment after platinum-based concurrent chemoradiotherapy (cCRT) has become the standard of care in inoperable stage III non-small cell lung cancer (NSCLC). In this nationwide survey, we solicited members of the German Radiation Oncology Society to review the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Roengvoraphoj, Olarn, Belka, Claus, Manapov, Farkhad
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://ncbi.nlm.nih.gov/pubmed/32420068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.25
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars